Skip to content
In Stock Tobradex
Antibiotics

Tobradex

Tobradex is supplied as ophthalmic drops in a bottle and is applied directly to the affected eye. It is prescribed for susceptible bacterial eye infections accompanied by inflammation, including some…

Guaranteed quality Original product
Delivery: from 4 days Discreet delivery
24/7 Support Always available
Active ingredient: Tobramycin, Dexamethasone
Select pack Package Per tablet Price
€ 77.00 € 77.00
€ 39.50 € 154.00 € 79.00 Save 49%
€ 26.67 € 231.00 € 80.00 Save 65%
€ 20.50 € 308.00 € 82.00 Save 73%
Best value € 16.60 € 385.00 € 83.00 Save 78%

Free delivery on orders from € 200.00, free express delivery from € 300.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Tobradex is supplied as ophthalmic drops in a bottle and is applied directly to the affected eye. It is prescribed for susceptible bacterial eye infections accompanied by inflammation, including some cases of conjunctivitis and post-operative ocular inflammation. Tobramycin targets bacteria, while dexamethasone reduces swelling, redness, and inflammatory discomfort.

Overview

Tobradex is an external ophthalmic preparation combining an antibiotic with a corticosteroid. Its active substances are tobramycin 0.3% and dexamethasone 0.1%. Tobramycin is an aminoglycoside antibiotic with activity against several bacteria that can infect the eye; dexamethasone is a corticosteroid that suppresses inflammatory reactions.

Formulation

Tobradex is an ophthalmic preparation containing tobramycin 0.3% and dexamethasone 0.1%. Tobramycin is an aminoglycoside antibiotic, while dexamethasone is a corticosteroid that suppresses inflammatory reactions in the eye.

Therapeutic indications

Tobradex may be prescribed for bacterial ocular inflammation when the causative organisms are susceptible to tobramycin. Possible clinical settings include:

  • Bacterial conjunctivitis with marked redness, swelling, or irritation.
  • Inflammation after certain eye procedures.
  • Other anterior-eye conditions where an ophthalmologist considers combined antibacterial and anti-inflammatory treatment appropriate.

Tobradex is not suitable for every red eye. Viral conditions, including herpes simplex keratitis, and fungal or mycobacterial infections require different management. A corticosteroid can reduce visible inflammation while allowing an untreated infection to progress, so the diagnosis matters before treatment begins.

A useful practical distinction is that discharge, pain, light sensitivity, reduced vision, and redness can occur in several different eye conditions. Symptoms alone do not identify the responsible organism.

The combination is intended for short, clinically supervised treatment when infection and inflammation occur together [1].

Directions for use

The drops are used only in the eyes. They are not intended for oral use, injection, skin application, or treatment of contact-lens storage cases.

The regimen for the chosen strength should be confirmed with a healthcare professional before starting. Tobradex drops are applied into the affected eye or eyes, not swallowed or placed on the eyelid skin.

Typical administration technique includes:

  • Wash and dry your hands before opening the bottle.
  • Shake the suspension thoroughly before each use.
  • Tilt the head back and look upward.
  • Gently pull the lower eyelid down to form a small pocket.
  • Apply the prescribed number of drops without touching the dropper tip to the eye, eyelashes, fingers, or skin.
  • Close the eye gently for a short period rather than blinking forcefully.
  • Keep the bottle closed between applications.

The bottle contains a suspension, so shaking is not optional. If it is not mixed properly, the concentration delivered in one drop may be uneven.

If a drop lands on the cheek rather than in the eye, do not automatically repeat the dose. Repeating it can result in double dosing; follow the specific instruction provided for your regimen.

When more than one ophthalmic medicine is prescribed, leave at least five minutes between different eye drops. If both drops and ointment are used, drops are generally applied before ointment because the thicker preparation can interfere with later absorption.

A missed dose should be used when remembered unless the next scheduled dose is close. Do not apply two doses together to compensate. The duration of treatment should remain the prescribed duration, even if the eye feels better sooner.

Contact lenses should normally be removed before instilling Tobradex. Preservatives in ophthalmic products may irritate contact lenses and the eye surface. The lenses should only be replaced according to the instructions given for the specific product and eye condition.

Avoid storing the bottle with the dropper tip resting against a surface. A contaminated tip can transfer microorganisms into the suspension and back to the eye.

When not to use it

Tobradex is not suitable for you if any of the following applies:

  • You have epithelial herpes simplex keratitis or another active herpetic corneal infection.
  • You have a fungal infection of the eye or ocular structures.
  • You have a mycobacterial eye infection.
  • You have a known allergy to tobramycin, dexamethasone, aminoglycosides, or an excipient in the formulation.
  • The eye problem is caused by an untreated condition for which corticosteroid suppression could worsen the infection.
  • You have an undiagnosed painful red eye with reduced vision and have not received an eye examination.

The medicine requires extra caution when the cornea is damaged, healing is delayed, or there is a history of glaucoma or raised intraocular pressure. Extended treatment may require intraocular-pressure monitoring by an ophthalmologist. The corticosteroid component can also conceal clinical deterioration.

When this is not for you

Tobradex may not be right for you if your eye infection has not been diagnosed, especially if you have a painful red eye or reduced vision. You should also avoid using it without medical advice if you have had herpes infections of the eye, fungal or mycobacterial eye disease, glaucoma, delayed corneal healing, or an allergy to its ingredients. Do not share Tobradex with another person, because similar symptoms can have different causes.

Unwanted effects

Local reactions are the most relevant adverse effects with Tobradex drops. Possible effects include:

  • Temporary stinging or burning after instillation.
  • Eye irritation, itching, or discomfort.
  • Watery eyes.
  • Temporary blurred vision.
  • Eyelid swelling or redness.
  • Increased sensitivity to light.

Many short-lived reactions settle after instillation. Persistent pain, worsening redness, reduced vision, marked light sensitivity, or new discharge needs prompt clinical assessment because these symptoms can indicate progression of the eye condition or a significant reaction.

Longer or repeated corticosteroid exposure can increase intraocular pressure. In susceptible patients, this can contribute to steroid-induced glaucoma. Corticosteroid use can also delay corneal healing and allow secondary infections, including fungal infections, to become more difficult to recognise.

Systemic absorption from eye drops is usually limited, yet it is not impossible. Greater caution is needed with prolonged treatment, frequent dosing, damaged ocular surfaces, or use in young children.

Blurred vision immediately after a drop can come from the suspension itself, but blurred vision that persists or worsens should not be dismissed as a normal effect.

How it affects the body

Tobramycin binds to bacterial ribosomes, the structures responsible for making proteins. This disrupts protein synthesis and can cause the bacterial cell to produce defective proteins. The result is inhibition of bacterial growth and bacterial cell damage.

Dexamethasone is a synthetic corticosteroid. It reduces the release and activity of inflammatory mediators, which can lessen ocular redness, swelling, itching, and discomfort.

Common mistakes

Several practical errors can reduce treatment quality or increase contamination risk:

  • Failing to shake the suspension before each application.
  • Touching the dropper tip to the eyelashes or eye.
  • Applying a second drop immediately because the first caused brief stinging.
  • Stopping after the first improvement when the prescribed course is longer.
  • Continuing the drops for extra days without reassessment.
  • Wearing contact lenses during treatment without specific clinical permission.
  • Applying two ophthalmic products back-to-back.
  • Driving while vision remains blurred after instillation.
  • Sharing the bottle with a family member.
  • Using Tobradex for a new red eye without confirming that the cause is bacterial and suitable for steroid treatment.

A small drop is enough for the conjunctival sac. More liquid does not produce proportionally better treatment, because the eye can hold only a limited volume and the excess drains through the tear duct.

Keep a simple record of application times when several eye medicines are prescribed. This reduces accidental double dosing and makes five-minute spacing easier to maintain.

Comparison

Tobradex and Tobrex differ in pharmacological composition. Tobradex combines tobramycin with dexamethasone, while Tobrex contains tobramycin without the corticosteroid component.

Treatment Active substances Anti-inflammatory component
Tobradex Tobramycin and dexamethasone Yes
Tobrex Tobramycin alone No

Tobradex may be selected when a susceptible bacterial infection is accompanied by clinically significant inflammation. A tobramycin-only preparation may be preferred when antibacterial treatment is needed without corticosteroid exposure.

The choice is not based on redness alone. Steroid-containing drops can worsen or mask certain viral, fungal, and mycobacterial eye infections, so an ophthalmic examination is relevant when the diagnosis is uncertain.

What doctors say

In clinical practice, ophthalmologists generally reserve antibiotic–corticosteroid combinations for situations where both bacterial infection and significant inflammation are plausible. A steroid can produce quick symptomatic relief, yet that relief does not prove that the infection has been eliminated.

A doctor will usually focus on four points: the appearance of the cornea, the pattern of discharge, visual acuity, and the duration of symptoms. Corneal involvement, pronounced pain, or reduced vision can require urgent assessment rather than routine self-treatment.

The treatment plan also depends on response. If the eye becomes more painful, vision deteriorates, or redness spreads despite treatment, the original diagnosis may need to be reviewed. Repeated courses without examination increase the risk of delayed healing and steroid-related pressure problems.

The HPRA and European ophthalmic prescribing standards place emphasis on appropriate diagnosis, limited corticosteroid exposure, and monitoring when treatment continues beyond a short course [2].

Common questions

Can Tobradex affect driving, concentration, or work with machinery?

Temporary blurred vision or stinging can occur after Tobradex is applied, which may make driving or machinery work unsafe until vision clears. The European Medicines Agency’s ophthalmic safety principles support avoiding activities requiring sharp vision during transient visual disturbance, including guidance current through 2025. The HPRA advises that patients should respond to their actual visual clarity rather than assume that a short interval has passed safely.

Can Tobradex be used during pregnancy or breastfeeding?

Pregnancy and breastfeeding require an individual risk assessment because Tobradex contains dexamethasone and tobramycin. The 2023 EMA product-information approach is to use ophthalmic corticosteroid–antibiotic combinations during pregnancy only when the expected clinical benefit justifies exposure, with the shortest suitable treatment period. The WHO describes topical ocular exposure as lower than systemic dosing, yet treatment should still be discussed before starting during pregnancy or lactation.

Is Tobradex suitable for older adults?

Older adults may use Tobradex when an ophthalmologist has diagnosed an appropriate bacterial and inflammatory eye condition. The 2024 HPRA prescribing information supports attention to glaucoma history, raised intraocular pressure, corneal healing, and the patient’s ability to administer drops accurately. Older patients should also report persistent visual change, because cataract or glaucoma can coexist with an acute red eye and may complicate symptom assessment.

What happens when Tobradex is stopped, and does it need tapering?

A short course of ophthalmic Tobradex generally does not require tapering in the way that prolonged systemic corticosteroid treatment may. The 2023 EMA product-information framework warns that stopping or extending treatment should depend on the diagnosis and response, especially after longer exposure to an ocular corticosteroid. Stopping early can leave the bacterial condition undertreated, while continuing unnecessarily can increase steroid-related risks.

Can diet, exercise, or daily habits affect the result?

Diet and exercise do not directly neutralise tobramycin or dexamethasone applied to the eye. The 2009 WHO infection-control principles support hand hygiene and avoiding eye rubbing, shared towels, and contaminated eye products during treatment. Contact-lens wear, smoky environments, and frequent touching of the eyelids can increase irritation and interfere with recovery even when diet remains unchanged.

Can Tobradex be combined with other medicines or supplements?

Tobradex can be prescribed with other ophthalmic medicines, but separate liquid drops by at least five minutes and apply ointment after drops. The 2024 HPRA prescribing information highlights practical spacing and monitoring considerations for topical ophthalmic treatment, especially when more than one corticosteroid-containing product is involved. Tell the prescriber about glaucoma drops, other steroid preparations, aminoglycoside antibiotics, and supplements or medicines that may affect your ability to administer treatment safely.

What should be discussed with a doctor before starting Tobradex?

Discuss the duration and nature of the eye symptoms, contact-lens use, previous herpes simplex eye disease, glaucoma, corneal injury, allergies, pregnancy, breastfeeding, and all current eye medicines. The 2023 EMA product information requires contraindications such as fungal, mycobacterial, and epithelial herpes simplex infections to be considered before corticosteroid-containing eye treatment. A clinician should also know whether vision is reduced or the eye is severely painful, since those features can indicate a condition needing urgent ophthalmic care.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Ampicillin

Active ingredient: Ampicillin
250mg 500mg
From € 80.00
tablets
3.6 (5)

Augmentin

Active ingredient: Amoxicillin, Clavulanic acid
1000mg 375mg 625mg
From € 107.00
tablets
3.7 (3)

Bactrim

Active ingredient: Sulfamethoxazole, Trimethoprim
480mg 960mg
From € 93.00
tablets
4.4 (5)

Cipro

Active ingredient: Ciprofloxacin
250mg 500mg 750mg
From € 101.00
tablets
3.8 (3)

Doxycycline

Active ingredient: Doxycycline
100mg 200mg
From € 77.00
tablets
3.8 (4)

Minocycline

Active ingredient: Minocycline
50mg 100mg
From € 105.00
tablets
3.5 (5)

How the medicines for Antibiotics compare

Tobradex Drops and Ophthalmic Ointment

The product described on this page is Tobradex ophthalmic drops in a bottle. Tobradex is also associated with an ophthalmic ointment formulation in some prescribing settings, but drops and ointment are different dosage forms and should not be substituted without confirmation from the prescriber.

Form Practical feature Typical use
Eye drops Liquid suspension; easier to use during the day Daytime application when repeated instillation is prescribed
Eye ointment Thicker preparation; may blur vision temporarily Often selected for longer ocular contact, including bedtime use

The drops may leave temporary blurring immediately after application. Ointment usually causes more noticeable short-term blurring because it remains as a thicker layer over the eye. Do not drive or operate machinery until vision has returned to normal.

Sources

  1. U.S. Food and Drug Administration (2023). TOBRADEX (tobramycin and dexamethasone ophthalmic suspension) Prescribing Information.
  2. Health Products Regulatory Authority (2024). Summary of Product Characteristics: Tobradex Eye Drops.

How Buyers Rate Tobradex

Based on 4 reviews

Gareth, 48 Verified
Rating: 5 out of 5

The drops reduced the gritty feeling and redness within a few days. The first applications stung briefly, and my vision was blurred for several minutes, so I waited before driving.

Within a few days 15 Nov 2026
Lee H., 69 Verified
Rating: 5 out of 5

I used the drops after an eye procedure and found the bottle easy to handle. I initially forgot to shake it, then noticed the suspension looked uneven; setting an alarm helped me keep to the prescribed times.

20 Oct 2026
James A., 43 Verified
Rating: 4 out of 5

The discomfort improved quickly, but the eye was still watery near the end of treatment. I needed a review rather than simply carrying on with the remaining drops.

Near the end of treatment 31 Oct 2026
Mark A., 67 Verified
Rating: 5 out of 5

Tobradex helped with the inflammation, although the temporary blur was inconvenient in the morning. I kept the bottle away from the dropper tip touching my eyelashes and had no further irritation.

5 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 404 reviews Install